Response to "Late relapse rates in patients with early-stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy".

Autor:	Burkbauer L; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Goldbach M; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Pomponio M; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Tchou J; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Jazyk:	angličtina
Zdroj:	Journal of surgical oncology [J Surg Oncol] 2020 May; Vol. 121 (6), pp. 1043. Date of Electronic Publication: 2020 Feb 17.
DOI:	10.1002/jso.25867
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text